TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT06965504: INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery

Sponsor: Abiomed Inc. · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 250 pts

Competing Trials Overlap

11 Active Trials

Excess Burn Exposure

$1,992,000

Rescue Site Savings

+$1,328,000

Unlock Full NCT06965504 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06965504 Rescue Dossier →